Research Topics
| Alan TyndallSummaryAffiliation: University of Basel Country: Switzerland Publications
| Collaborators
|
Detail Information
Publications
High-dose immunoablative therapy with hematopoietic stem cell support in the treatment of severe autoimmune disease: current status and future directionAlan Tyndall
Department of Rheumatology, University of Basel, Switzerland
Intern Med 41:608-12. 2002..The concept of immunological "re-setting" has evolved, and needs to be confirmed by longer follow-up and the multicentre, international phase III randomized studies...
Successes and failures of stem cell transplantation in autoimmune diseasesAlan Tyndall
University of Basel, Basel, Switzerland
Hematology Am Soc Hematol Educ Program 2011:280-4. 2011..Despite encouraging small phase 1/2 studies, no positive data from randomized, prospective studies are as yet available in the peer-reviewed literature...
Modern therapeutic strategies for autoimmune diseasesAlan Tyndall
Department of Rheumatology, University of Basel, Felix Platter Spital, Burgfelderstrasse 101, 4012, Basel, Switzerland
Curr Pharm Des 18:4508-12. 2012..Experimental strategies to achieve this include pre-emptive (preclinical) treatment before chronification is established, total immune ablation and immune "resetting" and autoantigen immunisation...
Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research groupChingching Foocharoen
Department of Rheumatology, Basel University, Burgfelderstrasse 101, Basel 4012, Switzerland
Arthritis Res Ther 14:R37. 2012..Erectile dysfunction (ED) is common in men with systemic sclerosis (SSc) but the demographics, risk factors and treatment coverage for ED are not well known...
Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseasesAlan Tyndall
Department of Rheumatology, Felix Platter Spital, University of Basel, Basel, Switzerland
Pediatr Res 71:433-8. 2012..Despite encouraging small phase I/II studies, no positive data from randomized, prospective studies are as yet available in the peer-reviewed literature...
Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directionsA Tyndall
Department of Rheumatology, University Hospital Basle, Basle, Switzerland
Clin Exp Immunol 141:1-9. 2005..In those who relapsed, many responded to agents which pre transplant had been ineffective. The study of immune reconstitution and gene expression pre and post HSCT is being undertaken to further understand the mechanism of autoimmunity...
Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricksA Tyndall
Department of Rheumatology, University of Basel, University Rheumatology Clinic, Basel, Switzerland
Bone Marrow Transplant 43:821-8. 2009..Multidisciplinary groups are collaborating to ensure maximal use of available resources to establish the place, if any, of MSC in the treatment of AD...
[Rheumatoid arthritis--pearls and myths]A Tyndall
, Felix Platter-Spital, Basel
Ther Umsch 62:269-71. 2005
Chronic GVHD as an autoimmune diseaseAlan Tyndall
Department of Rheumatology, University of Basel, Felix Platter Spital, Burfelderstrasse 101, 4012 Basel, Switzerland
Best Pract Res Clin Haematol 21:281-9. 2008....
Systemic sclerosis in Europe: first report from the EULAR Scleroderma Trials And Research (EUSTAR) group databaseA Tyndall
Department of Rheumatology, Felix Platter Spital, CH-4012, Basel, Switzerland
Ann Rheum Dis 64:1107. 2005
Autologous hematopoietic stem cell transplantation for autoimmune diseasesAlan Tyndall
Department of Rheumatology, University Hospital, Basel, Switzerland
Acta Haematol 114:239-47. 2005..Basic science programs are also being undertaken to study the immunological mechanisms underlying the clinical events observed...
Why do we need noncommercial, investigator-initiated clinical trials?Alan Tyndall
Department of Rheumatology, University of Basel, Switzerland
Nat Clin Pract Rheumatol 4:354-5. 2008
Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005Alan Tyndall
Rheumatology, University Hospital Basel, Felix Platter Spital, Burgfelderstrasse 101, Basel, CH 4012, Switzerland
Arthritis Res Ther 9:301. 2007..This review summarizes the findings of a 1-day meeting devoted to the subject with the aim of coordinating efforts...
Adult stem cell treatment of sclerodermaAlan Tyndall
Department of Rheumatology, University of Basel, Switzerland
Curr Opin Rheumatol 19:604-10. 2007....
Cellular therapy of systemic lupus erythematosusA Tyndall
Department of Rheumatology, University of Basel, Felix Platter Hospital, 4012, Basel, Switzerland
Lupus 18:387-93. 2009..Mesenchymal stem cells are in an exploratory phase for the treatment of acute autoimmune disease including SLE. The principle is that they home to inflammed tissue and exert an antiinflammatory paracrine effect...
Stem cells and rheumatology: update on adult stem cell therapy in autoimmune diseasesAlan Tyndall
University Hospital, Basle, Switzerland
Arthritis Rheum 55:521-5. 2006
News in autoimmune diseaseA Tyndall
Department of Rheumatology, University of Basel Kantonsspital
Schweiz Med Wochenschr 130:113-8. 2000..We must not forget the aim of improving quality of life for our patients, and not just improvement of immunological laboratory parameters...
Immune ablation and stem-cell therapy in autoimmune disease. Clinical experienceA Tyndall
Department of Rheumatology, University of Basel, Basel, Switzerland
Arthritis Res 2:276-80. 2000..No one regimen was clearly superior to another, with a trend toward more infectious complications with more intense regimens. Prospective, controlled randomized trials are indicated and being planned...
Immunoablation and haemopoietic stem cell transplantation for severe autoimmune disease with special reference to systemic lupus erythematosusA Tyndall
University Department of Rheumatology, Felix Platter Spital, Burgfelderstrasses 101, Basal 4012, Switzerland
Lupus 10:214-5. 2001..Randomised, prospective controlled phase III trials are desired, but by consensus, more phase I and II data is required to plan the optimal protocol...
Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000A Tyndall
Department of Rheumatology, University Hospital, Basel, Switzerland
Ann Rheum Dis 60:702-7. 2001..Further phase I and II data are required in SLE, JIA, and vasculitis. The need for continuing collection of all cases after mobilisation by the standardised EBMT and IBMTR data forms was emphasised...
Autologous hematopoietic stem cell transplantation for severe autoimmune disease with special reference to rheumatoid arthritisA Tyndall
Department of Rheumatology, University of Basel, Switzerland
J Rheumatol Suppl 64:5-7. 2001..Randomized, prospective controlled phase III trials have begun in SSc and will soon commence in RA and multiple sclerosis. More phase I and II data are required for systemic lupus erythematosus and juvenile idiopathic arthritis...
Haematopoietic stem cell transplantation for the treatment of systemic sclerosis and other autoimmune disordersAlan Tyndall
Department of Rheumatology, University of Basle, Felix Platter Spital, CH 4012, Basle, Switzerland
Expert Opin Biol Ther 3:1041-9. 2003..It is hypothesised that this results in fewer autoinflammatory and unwanted stimulatory signals to other systems such as vascular endothelium and fibroblasts, and these mechanisms are currently under study...
Future targets in the management of systemic sclerosisA Tyndall
Department of Rheumatology, Felix Platter Hospital, Basel, Switzerland
Rheumatology (Oxford) 48:iii49-53. 2009....
Adult stem cell transplantation in autoimmune diseaseAlan Tyndall
Department of Rheumatology, University of Basel, Switzerland
Curr Opin Hematol 16:285-91. 2009..In addition, the newly evolving field of mesenchymal stem cell therapy of autoimmune disease is introduced...
Stem cells in the treatment of inflammatory arthritisAlan Tyndall
Department of Rheumatology, University of Basel, Switzerland
Best Pract Res Clin Rheumatol 24:565-74. 2010....
Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review Thomas Daikeler
Department of Rheumatology, University of Basle, Petersgraben 4, CH 4031 Basle, Switzerland
Ann Rheum Dis 66:202-7. 2007..To evaluate the feasibility of haematopoietic stem cell transplantation (HSCT) in vasculitis...
Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donorAlicia Rovo
Department of Hematology, University Hospital of Basel, Basel, Switzerland
Haematologica 96:150-5. 2011..The study objective was to assess health status of very long-term survivors in comparison with their respective human leukocyte antigen-identical sibling donors...
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitisMartin Fuchs
Institute of Nuclear Medicine, University Hospital, Petersgraben 4, 4031 Basel, Switzerland
Eur J Nucl Med Mol Imaging 39:344-53. 2012..We aimed to assess the impact of (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) on the management of patients with suspected large vessel vasculitis...
The survey on cellular and engineered tissue therapies in Europe in 2009Ivan Martin
Department of Surgery, University Hospital Basel, Basel, Switzerland
Tissue Eng Part A 17:2221-30. 2011..This year's edition specifically describes and discusses the use of MSC for the treatment of autoimmune diseases, due to the scientific, clinical, and economical implications of this topic...
The EULAR Scleroderma Trials and Research Group (EUSTAR): an international framework for accelerating scleroderma researchAlan Tyndall
Department of Rheumatology, University of Basel, Basel, Switzerland
Curr Opin Rheumatol 20:703-6. 2008....
Adult stem cells in the treatment of autoimmune diseasesJ M van Laar
Department of Rheumatology, University of Basel, Felix Platter Spital, Burgfelderstrasse 101, Basel 4012, Switzerland
Rheumatology (Oxford) 45:1187-93. 2006..Such cells are immune privileged and apparently of low toxicity. Further characterization of these cells and consideration of their possible clinical application in AD is underway...
The survey on cellular and engineered tissue therapies in europe in 2010Ivan Martin
1 Department of Surgery and of Biomedicine, University Hospital Basel, Basel, Switzerland
Tissue Eng Part A 18:2268-79. 2012..This year's edition specifically discusses scientific, clinical, regulatory, and commercial aspects related to the use of cell therapy for the repair of cartilage defects...
Autoimmunity following haematopoietic stem-cell transplantationThomas Daikeler
Department of Rheumatology, University of Basel, University Hospital Basel, Petersgraben 4, CH 4058 Basel, Switzerland
Best Pract Res Clin Haematol 20:349-60. 2007..Prospective data for a better understanding of autoimmunity and 'altered' immunity after stem-cell transplantation are needed...
Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working PartyThomas Daikeler
Department of Rheumatology, University Hospital Basel, Basel, Switzerland
Blood 118:1693-8. 2011..This European multicenter study underlines the need for careful management and follow-up for secondary AD after HSCT...
Cellular therapy of systemic sclerosisJacob M van Laar
Department of Rheumatology, Felix Platter Spital, University of Basel, Burgfelderstrasse 101, Basel 4012 Switzerland
Curr Rheumatol Rep 10:189-94. 2008..Therapies involving mesenchymal stromal cells are currently being explored in clinical settings because of their anti-inflammatory and tissue regenerative properties and their favorable risk/benefit ratio...
Rheumatic conditions in human immunodeficiency virus infectionU A Walker
Department of Rheumatology, Basel University, Basel, Switzerland
Rheumatology (Oxford) 47:952-9. 2008..Thus, rheumatic diseases and asymptomatic immune phenomena remain prevalent in HIV-infected persons even after the widespread implementation of highly active anti-retroviral therapy...
Allogeneic hematopoietic SCT for patients with autoimmune diseasesT Daikeler
Department of Rheumatology, University of Basel, University Hospital, Basel CH 4031, Switzerland
Bone Marrow Transplant 44:27-33. 2009..However, allogeneic HSCT can induce remission in patients suffering from refractory AD. These data provide the basis for carefully conducted prospective trials...
Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15C Bocelli-Tyndall
Institute of Surgical Research and Hospital Management and Department of Biomedicine, University Hospital Basel, Basel, Switzerland
Ann Rheum Dis 68:1352-9. 2009....
Erectile dysfunction in systemic sclerosisU A Walker
Department of Rheumatology, Basel University, Basel, Switzerland
Ann Rheum Dis 68:1083-5. 2009..When intracavernous injections of prostaglandin E1 (alprostadil) are ineffective, the implantation of a penile prosthesis may be considered. Complex treatment options may require the involvement of urology...
Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group databaseU A Walker
Felix Platter Spital, Basel, Switzerland
Ann Rheum Dis 68:856-62. 2009..The aetiology is unknown. Genetic and environmental susceptibility factors have been implicated. It is unknown whether disease presentation varies within Europe...
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group databaseU A Walker
Department of Rheumatology, Basle University, Felix Platter Spital, Burgfelderstrasse 101, Basel 4012, Switzerland
Ann Rheum Dis 66:754-63. 2007..In order to better understand the vascular, immunological and fibrotic processes of SSc and to guide its treatment, the EULAR Scleroderma Trials And Research (EUSTAR) group was formed in June 2004...
Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitroC Bocelli-Tyndall
Department of Rheumatology, University of Basel, Basel, Switzerland
Rheumatology (Oxford) 46:403-8. 2007....
Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cellsChiara Bocelli-Tyndall
University Hospital Basel and University of Basel, Basel, Switzerland
Arthritis Rheum 62:3815-25. 2010....
Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regionsMarkus Aschwanden
Department of Rheumatology, University Hospital Basel, Petersgraben 4, Basel CH 4031, Switzerland
Ann Rheum Dis 69:1356-9. 2010..To define the specificity and extent of duplex sonography (DS) findings suggestive of vessel wall inflammation in patients with giant cell arteritis (GCA)...
Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTRJohn A Snowden
Department of Rheumatology, Felix-Platter-Spital, University of Basel, Basel, Switzerland
J Rheumatol 31:482-8. 2004..Clinical trials are necessary to develop this approach in patients with aggressive disease who have failed conventional treatment including anti-tumor necrosis factor agents...
Autologous hematopoietic stem cell transplantation for autoimmune diseasesA Gratwohl
University Hospital, Basel, Switzerland
Bone Marrow Transplant 35:869-79. 2005..81 (0.96-3.42)); low intensity, RR2.34 (1.074-5.11)). These data from the collective EBMT experience support the hypothesis that autologous HSCT can alter disease progression in severe autoimmune disease...
[Pericardial effusion in a 21-year-old employee]St Wiggli
, Felix Platter Spital, Basel
Praxis (Bern 1994) 95:419-21. 2006
Haematopoetic stem cell transplantation for refractory autoimmune cytopeniaJ R Passweg
Basel University Hospitals, Basel, Switzerland
Br J Haematol 125:749-55. 2004..Autologous and allogeneic HSCT may induce a response in a subset of patients with autoimmune cytopenia of long duration albeit at the price of considerable toxicity...
A survey on cellular and engineered tissue therapies in europe in 2008Ivan Martin
Department of Surgery and of Biomedicine, University Hospital, Basel, Switzerland
Tissue Eng Part A 16:2419-27. 2010..This data collection platform is expected to capture and foresee trends for novel cellular therapies in Europe, and warrants further consolidation and extension...
Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapyS Kroesen
Department of Rheumatology, University Hospital, Basel, Switzerland
Rheumatology (Oxford) 42:617-21. 2003..CONCLUSIONS: A high level of suspicion of infection is necessary in patients under anti-TNF-alpha therapy. We suggest additional strategies for the prevention, rapid identification and pre-emptive therapy of such infections...
[Hematopoietic stem cell transplantations in treatment of autoimmune diseases]A Gratwohl
Department Innere Medizin Kantonsspital, Basel, Switzerland
Z Rheumatol 56:173-7. 1997..Clear clinical data are still missing. Preliminary data are promising and protocols for prospective studies are being prepared. They should allow a better evaluation of the procedures in a few years from now...
A comparison between ((3)H)-thymidine incorporation and isothermal microcalorimetry for the assessment of antigen-induced lymphocyte proliferationC Murigande
Department of Rheumatology, Felix Platter Spital, Basel, Switzerland
Immunol Invest 38:67-75. 2009..Our study suggests that IMC measurements, despite the advantages of simplicity, on-line recording of metabolic activity and no use of radioactivity, may be limited to monitoring mitogen-induced lymphocyte proliferation...
Autologous stem cell transplantation of treatment-resistant systemic vasculitis--a single center experience and review of the literatureI Kotter
University Hospital, Department of Internal Medicine II Oncology, Hematology, Immunology, Rheumatology, Pulmology, Tubingen, Germany
Clin Nephrol 64:485-9. 2005..We intended to analyze the effects of autoPBSCT in patients with treatment-resistant systemic vasculitis by analyzing the outcome of 4 patients from our own hospital, and comparing them to cases reported in the literature...
Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) databaseDaniel Schneeberger
Department of Rheumatology, Basel University, Felix Platter Spital, Burgfelderstr 101, 4012 Basel, Switzerland
Rheumatology (Oxford) 52:560-7. 2013..Prospective studies are needed to elucidate the clinical presentation, evolution and outcome of such patients...
Multisegmental spondylitis due to Tropheryma whipplei: case reportDavid Spoerl
Department of Rheumatology, University of Basel, Felix Platter Spital, Basel, Switzerland
Orphanet J Rare Dis 4:13. 2009..In this clinical setting, routine PCR for Tropheryma whipplei from vertebral biopsies is recommended...
Bone marrow histology in a patient with fever of unknown originAndreas Holbro
Department of Internal Medecine, University Hospital Basel, Basel, Switzerland
J Rheumatol 35:530-1. 2008
Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritisXiao Yan Zhong
Laboratory for Prenatal Medicine, University Women s Hospital, Department of Research, University Hospital Basel, Basel, Switzerland
Clin Chem 53:1609-14. 2007..Evidence from in vitro and animal experiments suggests that DNA may play a role in the pathogenesis of rheumatoid arthritis (RA)...
Human articular chondrocytes suppress in vitro proliferation of anti-CD3 activated peripheral blood mononuclear cellsChiara Bocelli-Tyndall
Department of Rheumatology, University of Basel, Felix Plattel Spital, Burgfelderstrasse 101, 4012 Basel, Switzerland
J Cell Physiol 209:732-4. 2006..To investigate whether mature human articular chondrocytes (AC) exhibit an antiproliferative effect on activated peripheral blood mononuclear cells (PBMC) and to compare this effect with other cells of mesenchymal origin...
Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced?T Hugle
Felix Platter Spital, Basel University Department of Rheumatology, Switzerland
Ann Rheum Dis 68:47-50. 2009..To describe and analyse the manifestation of sclerosing skin disorders in patients with multiple sclerosis (MS)...
Serum procalcitonin for discrimination between septic and non-septic arthritisT Hugle
Department of Rheumatology, University Hospital Basel, Switzerland
Clin Exp Rheumatol 26:453-6. 2008..Early differentiation between septic and non-septic arthritis is difficult. A previous study showed promising diagnostic accuracy of serum Procalcitonin (PCT) in septic arthritis, limited by a low sensitive PCT test kit...
Tenofovir-induced osteomalaciaD P Wanner
Department of Rheumatology, Basle University, Basel, Switzerland
Clin Exp Rheumatol 27:1001-3. 2009..Awareness is needed to link the typically prolonged onset of clinical symptoms with TDF exposure and then establish the correct diagnosis...
Focal myositis of the iliopsoas muscle--a benign pseudotumour: ultrasound appearance in correlation with CT and MRIA Hoffmann
Department of Radiology, University Hospital Basel, Switzerland
Ultraschall Med 27:180-4. 2006..Focal myositis of the iliopsoas muscle is a rare condition. A case is presented, emphasizing the value of ultrasound for detection, localisation, image-guided biopsy and follow-up in correlation with CT and MRI findings...
Discriminatory ability of quantitative ultrasound parameters and bone mineral density in a population-based sample of postmenopausal women with vertebral fractures: results of the Basel Osteoporosis StudyF Hartl
Department of Rheumatology, Felix Platter-Hospital, University of Basel, Switzerland
J Bone Miner Res 17:321-30. 2002..However, the performance of QUS measurements is at least comparable with DXA measurements in identifying subjects with multiple vertebral fractures randomly selected from the population...
[Spondylodiscitis without fever: a diagnostic challenge]J Luthy
Rheumatologische Universitätsklinik, Felix Platter Spital und Universitätsspital, Basel
Dtsch Med Wochenschr 133:1725-9. 2008..EXAMINATIONS, DIAGNOSIS: In all three patients the MRI of the affected vertebral column was consistent with vertebral osteomyelitis. Microbiological diagnosis was made by bone biopsy in all patients and by blood cultures in two of them...
Allogeneic bone marrow transplantation for autoimmune disease--the jury is still outAlan Tyndall
J Rheumatol 33:644-6. 2006
Autologous stem cell transplantation in autoimmune diseasesJakob Passweg
Division of Hematology, University Hospital Geneva, Geneva, Switzerland
Semin Hematol 44:278-85. 2007....
Target populations in allogeneic hematopoietic cell transplantation for autoimmune diseases--a workshop accompanying: cellular therapy for treatment of autoimmune diseases, basic science and clinical studies, including new developments in hematopoietic anLinda M Griffith
Biol Blood Marrow Transplant 12:688-90. 2006
Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a reviewJacob M van Laar
Department of Rheumatology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
Cancer Control 10:57-65. 2003....
The use of high dose immunoablative therapy with hematopoietic stem cell support therapy in the treatment of severe autoimmune diseasesAlan Tyndall
Int J Hematol 76:218-22. 2002
Hematopoietic stem cell transplantation in autoimmune diseases: algorithm for cardiovascular assessmentIrene Miniati
Division Medicine I and Rheumatology, Department of Medicine and Surgery, University of Florence, Viale Pieraccini 18, 50139 Florence, Italy
Herz 32:43-50. 2007..The aim is to optimize cardiac status in order to allow intense immunosuppressive treatments...
Cell therapy for autoimmune diseasesFrancesco Dazzi
Stem Cell Biology Section, Kennedy Institute of Rheumatology, Imperial College Faculty of Medicine, London, UK
Arthritis Res Ther 9:206. 2007..All of these potential resources clearly need to be investigated at the preclinical level but support a great deal of enthusiasm for cell therapy of autoimmune diseases...
Scleroderma lung: pathogenesis, evaluation and current therapyJacob M van Laar
Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
Drugs 67:985-96. 2007..Uncontrolled studies have suggested that these therapies also have an impact on survival, but controlled studies with a long follow-up are needed to corroborate this point...
Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alphaCarlo Chizzolini
Division of Immunologya and Allergy, Geneva University Hospital, Geneva, Switzerland
Arthritis Rheum 48:2593-604. 2003....
Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysisAlicia Rovo
Blood 111:1740-1. 2008
Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 1Linda M Griffith
Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
Biol Blood Marrow Transplant 11:862-70. 2005
Autologous stem cell transplantation for systemic lupus erythematosusDavid Jayne
Department of Medicine, Addenbrooke s Hospital, Cambridge, UK
Lupus 13:168-76. 2004..The safety of this procedure is likely to be improved by patient selection and choice of conditioning regimen. The return of disease activity in one-third of patients might be reduced by long-term immunosuppressive therapy post-ASCT...
Rheumatology gone globalDaniel H Solomon
Ann Rheum Dis 67:1357. 2008
Rheumatology gone globalDaniel H Solomon
Arthritis Rheum 59:1369-70. 2008
